177 related articles for article (PubMed ID: 1323636)
1. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
[TBL] [Abstract][Full Text] [Related]
2. Effect of atrial natriuretic hormone on vasopressin and thirst response to osmotic stimulation in human subjects.
Wazna-Wesly JM; Meranda DL; Carey P; Shenker Y
J Lab Clin Med; 1995 Jun; 125(6):734-42. PubMed ID: 7769367
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic hormone effect on renal function and aldosterone secretion in sodium depletion.
Shenker Y
Am J Physiol; 1988 Dec; 255(6 Pt 2):R867-73. PubMed ID: 2974252
[TBL] [Abstract][Full Text] [Related]
6. Effect of atrial natriuretic hormone on hypertonic saline-induced suppression of the renin-aldosterone system.
Wazna J; Burge M; Meranda D; Shenker Y
Am J Hypertens; 1994 Jun; 7(6):543-9. PubMed ID: 7917153
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans.
Blumberg AL; Dubb JW; Allison NL; Aldins Z; Ramey K; Stote RM
J Cardiovasc Pharmacol; 1988 Feb; 11(2):181-6. PubMed ID: 2452312
[TBL] [Abstract][Full Text] [Related]
11. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism.
Clinkingbeard C; Sessions C; Shenker Y
J Clin Endocrinol Metab; 1990 Mar; 70(3):582-9. PubMed ID: 2137830
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic hormone and aldosterone regulation in salt-depleted state.
Shenker Y
Am J Physiol; 1989 Oct; 257(4 Pt 1):E583-7. PubMed ID: 2529776
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
14. Effect of varying potassium intake on atrial natriuretic hormone-induced suppression of aldosterone.
Clinkingbeard C; Lawrence D; Shenker Y
Am J Hypertens; 1991 May; 4(5 Pt 1):456-9. PubMed ID: 1829901
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations.
Richards AM; McDonald D; Fitzpatrick MA; Nicholls MG; Espiner EA; Ikram H; Jans S; Grant S; Yandle T
J Clin Endocrinol Metab; 1988 Dec; 67(6):1134-9. PubMed ID: 2973471
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.
Lang CC; Rahman AR; Struthers AD
Br J Clin Pharmacol; 1991 Jul; 32(1):51-6. PubMed ID: 1832287
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic regulation of extrarenal potassium metabolism.
Sager PT; DeFronzo RA
Miner Electrolyte Metab; 1987; 13(6):385-92. PubMed ID: 3320723
[TBL] [Abstract][Full Text] [Related]
18. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Coruzzi P
J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
[TBL] [Abstract][Full Text] [Related]
19. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
Malchoff CD; Hughes JM; Carey RM
J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
[TBL] [Abstract][Full Text] [Related]
20. Effect of atrial peptides on aldosterone production.
Atarashi K; Mulrow PJ; Franco-Saenz R
J Clin Invest; 1985 Nov; 76(5):1807-11. PubMed ID: 2997288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
